| Literature DB >> 26697501 |
Abdul-Razak Abubakari1, Rosanna Cousins2, Cecil Thomas3, Dushyant Sharma4, Ebrahim K Naderali2.
Abstract
Self-management is critical if people with diabetes are to minimise their risk of macrovascular and microvascular complications, yet adherence to self-management recommendations is suboptimal. Understanding the predictors of optimal diabetes self-management in specific populations is needed to inform effective interventions. This study investigated the role of demographic and clinical characteristics, illness perceptions, and self-efficacy in explaining adherence to self-management recommendations among people with poorly controlled diabetes in North West of England. Illness perceptions and self-efficacy data were collected using validated questionnaires and clinical data were obtained from hospital records. Correlations were used to investigate bivariate relationships between independent variables and self-management, and multiple regression techniques were used to determine demographic and psychosocial predictors of self-management. Various demographic and clinical characteristics were associated with adherence to self-management recommendations. In particular, employment status explained 11% of the variation in adherence to foot care whilst diabetes treatment category explained 9% of exercise and 21% of the variations in SMBG recommendations. Also, 22% and 8% of the variations in overall self-management were explained by illness perceptions and self-efficacy beliefs, respectively. Illness perceptions and self-efficacy beliefs of people with poorly controlled diabetes are important predictors of their self-management behaviours and could potentially guide effective interventions.Entities:
Mesh:
Year: 2015 PMID: 26697501 PMCID: PMC4678078 DOI: 10.1155/2016/6708164
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Bivariate relationships between sociodemographic and disease characteristic variables and psychosocial dependent variables.
| Variable | IP score | PDSMS score | Diet SMG | Exercise SMG | SMBG | Foot SMG | Overall SMG |
|---|---|---|---|---|---|---|---|
| Age | −0.03 | −0.02 | 0.03 | −0.12 | −0.01 | 0.24 | 0.08 |
| Sexpb | 0.04 | −0.10 | 0.12 | 0.03 | 0.18 | 0.02 | 0.16 |
| Marital status | 0.16 | −0.12 | −0.14 | −0.16 | −0.07 | −0.01 | −0.11 |
| Educational qualification | −0.16 | 0.16 | −0.09 | 0.12 | −0.01 | 0.10 | −0.02 |
| Ethnicity | 0.01 | 0.03 | 0.09 | 0.05 | −0.05 | 0.22 | 0.12 |
| Employment status | 0.23 | −0.09 | −0.04 | −0.20 | −0.04 | 0.08 | 0.01 |
| Diabetes type | 0.19 | −0.20 | 0.06 | −0.23 | −0.26 | 0.13 | −0.09 |
| Diabetes treatment type | 0.21 | −0.08 | 0.05 | −0.14 | 0.39 | 0.07 | 0.12 |
| Duration since diagnosis | −0.18 | 0.19 | −0.01 | 0.05 | 0.33 | 0.13 | 0.18 |
| BMI status | 0.21 | −0.13 | −0.08 | −0.19 | −0.16 | 0.15 | −0.10 |
| HbA1c (%) categories | −0.12 | 0.18 | −0.18 | 0.22 | 0.07 | 0.04 | 0.10 |
| BP statuspb | 0.07 | −0.01 | 0.12 | −0.01 | −0.09 | 0.15 | 0.02 |
| Retinopathy statuspb | −0.01 | 0.03 | −0.07 | −0.04 | 0.11 | 0.07 | 0.07 |
| Neuropathy statuspb | 0.24 | −0.14 | −0.11 | −0.20 | −0.08 | 0.13 | −0.09 |
| Nephropathy statuspb | 0.14 | −0.06 | 0.10 | 0.09 | −0.04 | 0.05 | 0.12 |
| IP score | −0.16 | −0.13 | −0.01 | 0.04 | −0.17 | ||
| PDSMS score | −0.16 | 0.19 | 0.10 | 0.17 | 0.29 |
ρ, spearman's rho; pb, point biserial correlation coefficient; all other correlation coefficients are Pearson's correlation coefficients.
p value ≤ 0.05; p value ≤ 0.01; p value ≤ 0.001.
IP, illness perception; PDSMS, Perceived Diabetes Self-Management Scale; SMG, self-management; SMBG, self-monitoring of blood glucose.
Predicting illness perceptions, self-efficacy, and adherence to self-management recommendations from sociodemographic and disease characteristics.
| Predictor variable |
| 95% CI |
|
|
|
|---|---|---|---|---|---|
| (1) | |||||
| (i) Consequences and demographic/disease characteristics | <0.01 | 0.12 | |||
| Constant | 2.88 (0.41) | 0.88–4.89 | ≤0.01 | ||
| Nephropathy status | 2.54 (1.03) | 0.48–4.59 | 0.02 | 0.254 | |
| diabetic tablets + insulin versus 1 diabetic tablet | 1.34 (0.57) | 0.20–2.48 | 0.02 | 0.242 | |
| HbA1c (%) | 0.04 (0.02) | 0.00–0.08 | 0.04 | 0.212 | |
| (ii) Timeline and demographic/disease characteristics | <0.001 | 0.56 | |||
| Constant | 9.78 (0.13) | 9.55–10.05 | <0.001 | ||
| ≥2 diabetic tablets versus 1 diabetic tablet | −0.67 (0.19) | −1.04–−0.30 | 0.001 | −0.34 | |
| Primary/secondary versus college/sixth form | −0.50 (0.13) | −0.77–−0.24 | <0.001 | −0.36 | |
| Duration since diagnosis | 0.02 (0.01) | 0.01–0.03 | <0.01 | 0.29 | |
| (iii) Personal control and demographic/disease characteristics | <0.001 | 0.38 | |||
| Constant | 12.79 (1.16) | 10.48–15.11 | <0.001 | ||
| Diabetes type | −2.78 (0.51) | −3.78–−1.79 | <0.001 | −0.56 | |
| HbA1c (%) | −0.07 (0.02) | −0.10–−0.04 | <0.001 | −0.39 | |
| Primary/secondary versus university/graduate | 1.30 (0.51) | 0.29–2.30 | 0.01 | 0.23 | |
| ≥2 diabetic tablets versus 1 diabetic tablet | 1.56 (0.73) | 0.12–3.00 | 0.03 | 0.21 | |
| (iv) Treatment control and demographic/disease characteristics | <0.001 | 0.27 | |||
| Constant | 13.00 (1.17) | 10.68–15.33 | <0.001 | ||
| Diabetes type | −1.73 (0.49) | −2.70–−0.75 | 0.001 | −0.36 | |
| HbA1c (%) | −0.05 (0.02) | −0.09–−0.02 | <0.01 | −0.30 | |
| Neuropathy status | −1.47 (0.59) | −2.64–−0.30 | 0.01 | −0.25 | |
| (v) Identity and demographic/disease characteristics | ≤0.001 | 0.17 | |||
| Constant | 4.63 (0.42) | 3.79–5.17 | <0.001 | ||
| diabetic tablets and insulin versus 1 diabetic tablet | 1.86 (0.60) | 0.67–3.05 | <0.01 | 0.32 | |
| Primary/secondary versus polytechnic | −2.44 (1.15) | −4.72–−0.15 | 0.04 | −0.22 | |
| (vi) Concern and demographic/disease characteristics | <0.001 | 0.15 | |||
| Constant | 8.22 (0.29) | 7.65–8.79 | <0.001 | ||
| insulin versus 1 diabetic tablet | −1.86 (0.48) | −2.81–−0.90 | <0.001 | −0.39 | |
| (vii) Illness coherence and demographic/disease characteristics | <0.01 | 0.14 | |||
| Constant | 5.82 (0.50) | 4.83–6.81 | <0.001 | ||
| Duration since diagnosis | 0.06 (0.02) | 0.02–0.11 | <0.01 | 0.30 | |
| Sex | 1.05 (0.46) | 0.14–1.96 | 0.02 | 0.24 | |
| (viii) Emotional response and demographic/disease characteristics | <0.01 | 0.09 | |||
| Constant | 6.67 (0.60) | 5.48–7.86 | <0.001 | ||
| Duration since diagnosis | −0.09 | −0.15–−0.03 | <0.01 | −0.30 | |
| (ix) Overall IP score and demographic/disease characteristics | <0.001 | 0.34 | |||
| Constant | 14.21 | −3.09–31.51 | 0.11 | ||
| diabetic tablets and insulin versus 1 diabetic tablet | 6.82 (2.22) | 2.40–11.23 | <0.01 | 0.29 | |
| Nephropathy status | 10.98 (3.87) | 3.27–18.70 | <0.01 | 2.84 | |
| Duration since diagnosis | −0.21 (0.11) | −0.42–0.00 | 0.06 | −0.19 | |
| HbA1c (%) | 0.27 (0.09) | 0.10–0.44 | <0.01 | 0.32 | |
| BMI | 0.48 (0.19) | 0.11–0.86 | 0.01 | 0.27 | |
| (2) |
|
| |||
| Constant | 31.87 (2.56) | 26.77–36.98 | <0.001 | ||
| Neuropathy status | −5.17 (1.63) | −8.42–−1.92 | <0.01 | −0.32 | |
| Duration since diagnosis | 0.17 (0.06) | 0.05–0.29 | <0.01 | 0.29 | |
| HbA1c (%) | −0.14 (0.05) | −0.24–−0.03 | 0.01 | −0.26 | |
| (3) | |||||
| (i) Diet/meal planning recommendations and demographic/disease characteristics | |||||
| No variable entered into the equation (no variable | |||||
| (ii) Exercise recommendations and demographic/disease characteristics |
|
| |||
| Constant | 2.21 (0.31) | 1.59–2.83 | <0.001 | ||
| Insulin versus 1 diabetic tablet | 1.47 (0.52) | 0.44–2.50 | 0.01 | 0.31 | |
| (iii) Blood testing recommendations and demographic/disease characteristics | 0.21 | ||||
| Constant | 5.17 (0.27) | 4.63–5.71 | <0.001 | ||
| ≥2 diabetic tablets versus 1 diabetic tablet | −3.49 (0.75) | −4.97–−2.00 | <0.001 | −0.46 | |
| (iv) Foot care recommendations and demographic/disease characteristics |
|
| |||
| Constant | 2.53 (0.26) | 2.02–3.05 | <0.001 | ||
| Employed versus not in work due to long-term illness/disability | 2.32 (0.75) | 0.82–3.81 | <0.01 | 0.32 | |
| (v) Overall SMG recommendations and demographic/disease characteristics | 0.02 | 0.07 | |||
| Constant | 3.79 (0.15) | 3.50–4.10 | <0.001 | ||
| ≥2 diabetic tablets versus 1 diabetic tablet | −0.99 (0.42) | −1.83–−0.16 | 0.02 | −0.26 | |
p value ≤ 0.05; p value ≤ 0.01; p value ≤ 0.001.
Predicting adherence to recommended self-management behaviours from psychosocial variables (illness perceptions or self-management-related self-efficacy).
| Predictor variable |
| 95% CI |
|
|
|
|---|---|---|---|---|---|
| (1) | |||||
| Diet recommendations and illness perceptions | 0.07 |
| |||
| Constant | 5.43 (2.05) | 1.37–9.48 | 0.01 | ||
| Consequences | 0.04 (0.08) | −0.13–0.21 | 0.65 | 0.06 | |
| Timeline | −0.26 (0.20) | −0.64–0.13 | 0.19 | −0.13 | |
| Personal control | 0.01 (0.08) | −0.15–0.17 | 0.93 | 0.01 | |
| Treatment control | 0.03 (0.09) | −0.15–0.17 | 0.73 | 0.04 | |
| Identity | −0.10 (0.07) | −0.24–0.03 | 0.13 | −0.16 | |
| Concern | −0.06 (0.08) | −0.22–0.09 | 0.42 | −0.09 | |
| Understand | 0.21 (0.08) | 0.05–0.37 | 0.01 | 0.27 | |
| Emotional response | 0.07 (0.07) | −0.07–0.21 | 0.33 | 0.12 | |
| Exercise recommendations and illness perceptions |
|
| |||
| Constant | 4.27 (2.76) | 1.21–9.75 | 0.13 | ||
| Consequences | 0.02 (0.12) | −0.23–0.26 | 0.90 | 0.02 | |
| Timeline | −0.36 (0.26) | −0.88–0.16 | 0.18 | −0.13 | |
| Personal control | −0.09 (0.12) | −0.33–0.14 | 0.43 | −0.10 | |
| Treatment control | 0.29 (0.13) | 0.02–0.56 | 0.03 | 0.27 | |
| Identity | −0.16 (0.09) | −0.35–0.02 | 0.08 | −0.19 | |
| Concern | −0.08 (0.11) | −0.30–0.15 | 0.50 | −0.08 | |
| Understand | 0.05 (0.11) | −0.17–0.27 | 0.65 | 0.05 | |
| Emotional response | 0.17 (0.10) | −0.03–0.36 | 0.09 | 0.22 | |
| SMBG recommendations and illness perceptions | 0.04 |
| |||
| Constant | −4.77 (3.11) | −10.94–1.40 | 0.13 | ||
| Consequences | 0.10 (0.13) | −0.15–0.36 | 0.42 | 0.11 | |
| Timeline | 0.66 (0.30) | 0.07–1.25 | 0.03 | 0.20 | |
| Personal control | −0.04 (0.13) | −0.29–0.21 | 0.75 | −0.04 | |
| Treatment control | 0.22 (0.15) | −0.08–0.51 | 0.15 | 0.18 | |
| Identity | 0.15 (0.10) | −0.05–0.35 | 0.15 | 0.15 | |
| Concern | −0.19 (0.12) | −0.43–0.05 | 0.11 | −0.18 | |
| Understand | 0.15 (0.12) | −0.10–0.39 | 0.24 | 0.12 | |
| Emotional response | 0.05 (0.11) | −0.16–0.27 | 0.62 | 0.06 | |
| Foot care recommendations and illness perceptions | 0.01 |
| |||
| Constant | 3.52 (2.73) | −1.90–8.94 | 0.20 | ||
| Consequences | 0.15 (0.11) | −0.07–0.38 | 0.17 | 0.18 | |
| Timeline | −0.39 (0.26) | −0.91–0.12 | 0.13 | −0.14 | |
| Personal control | 0.25 (0.11) | 0.04–0.46 | 0.02 | 0.25 | |
| Treatment control | −0.17 (0.13) | −0.42–0.07 | 0.17 | −0.17 | |
| Identity | 0.09 (0.09) | −0.08–0.26 | 0.31 | 0.10 | |
| Concern | −0.09 (0.10) | −0.29–0.12 | 0.41 | −0.09 | |
| Understand | 0.28 (0.11) | 0.06–0.49 | ≤0.01 | 0.26 | |
| Emotional response | 0.06 (0.09) | −0.12–0.25 | 0.50 | 0.08 | |
| Overall self-management recommendations and illness perceptions | 0.003 |
| |||
| Constant | 1.93 (1.44) | −0.92–4.79 | 0.18 | ||
| Consequences | 0.03 (0.07) | −0.10–0.16 | 0.66 | 0.06 | |
| Timeline | −0.06 (0.14) | −0.33–0.21 | 0.65 | −0.04 | |
| Personal control | 0.02 (0.06) | −0.10–0.15 | 0.71 | 0.04 | |
| Treatment control | 0.10 (0.07) | −0.05–0.24 | 0.18 | 0.16 | |
| Identity | −0.05 (0.05) | −0.15–0.05 | 0.30 | −0.11 | |
| Concern | −0.07 (0.06) | −0.18–0.05 | 0.30 | −0.13 | |
| Understand | 0.19 (0.06) | 0.08–0.31 | ≤0.001 | 0.33 | |
| Emotional response | 0.10 (0.05) | −0.001–0.20 | 0.05 | 0.23 | |
| (2) | |||||
| Diet recommendations and PDSMS score |
| ||||
| Constant | 3.50 (0.58) | 2.35–4.65 | <0.001 | ||
| Diabetes self-efficacy | 0.04 (0.02) | −0.001–0.08 | 0.05 | 0.18 | |
| Exercise recommendations and PDSMS score |
| ||||
| Constant | 0.88 (0.93) | −0.96–2.73 | 0.34 | ||
| Diabetes self-efficacy | 0.06 (0.03) | −0.00–0.13 | 0.05 | 0.19 | |
| SMBG recommendations and PDSMS score |
| ||||
| Constant | 3.46 (1.06) | 1.36–5.56 | 0.001 | ||
| Diabetes self-efficacy | 0.04 (0.04) | −0.04–0.12 | 0.29 | 0.10 | |
| Foot care recommendations and PDSMS score |
| ||||
| Constant | 1.28 (0.94) | −0.58–3.14 | 0.18 | ||
| Diabetes self-efficacy | 0.06 (0.03) | −0.01–0.13 | 0.07 | 0.17 | |
| Overall SMG recommendations and PDSMS score |
| ||||
| Constant | 2.23 (0.48) | 1.27–3.18 | <0.001 | ||
| Diabetes self-efficacy | 0.05 (0.02) | 0.02–0.09 | <0.01 | 0.29 |
p value ≤ 0.05; p value ≤ 0.01; p value ≤ 0.001.